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Although the methods for analyzing incidence
studies (and incidence case–control studies) are
now well established, there is still considerable
confusion and debate about the appropriate
methods for analyzing prevalence studies (and
prevalence case–control studies). In particular,
it has been argued that prevalence ratios are
the preferred method and that prevalence
odds ratios (PORs) should not be used. In this
article I argue that PORs should continue to
be one of the standard methods for analyzing
such studies. I brieﬂy review the relationship
between incidence and prevalence studies and
then discuss the relative merits of using PORs
and prevalence ratios.
Incidence Studies
Table 1 shows the ﬁndings of a hypothetical
incidence study of 20,000 persons followed
for 10 years (Pearce 2003). Three measures of
disease incidence are commonly used in inci-
dence studies (Pearce 1993): the person-time
incidence rate, the incidence proportion, and
the incidence odds. These all involve the same
numerator: the number of incident cases of
disease (b). They differ in whether their
denominators represent person-years at risk
(Y0), persons at risk (N0), or survivors (d).
The person-time incidence rate is a meas-
ure of the disease occurrence per unit popu-
lation time and has the reciprocal of time as
its dimension. In this example (Table 1),
there were 952 cases of disease diagnosed in
the nonexposed group during the 10 years of
follow-up, which involved a total of 95,163
person-years, and the person-time incidence
rate, b/Y0 = I0, was 952/95,163 = 0.0100 (or
1,000 per 100,000 person-years).
The incidence proportion, or average risk,
is a second measure of disease occurrence and
is the proportion of study subjects who expe-
rience the outcome of interest at any time
during the follow-up period. In this instance,
there were 952 incident cases among the
10,000 people in the nonexposed group, and
the incidence proportion, b/N0 = R0, was
therefore 952/10,000 = 0.0952 over the
10-year follow-up period. When the outcome
of interest is rare over the follow-up period
(e.g., an incidence proportion < 10%), then the
incidence proportion is approximately equal to
the incidence rate multiplied by the length of
time that the population has been followed (in
the example this product is 0.1000, whereas the
incidence proportion is 0.0952).
A third possible measure of disease occur-
rence is the incidence odds (Greenland 1987),
which is the ratio of the number of people who
experience the outcome (b) to the number of
people who do not experience the outcome (d).
As for the incidence proportion, the incidence
odds is dimensionless, but it is necessary to
specify the time period over which it is being
measured. In this example, the incidence odds,
b/d = O0, is 952/9,048 = 0.1052. When the
outcome is rare over the follow-up period, the
incidence odds is approximately equal to the
incidence proportion.
Corresponding to these three measures of
disease occurrence, there are three principal
ratio measures of effect that can be used in
incidence studies (Pearce 1993): the rate ratio,
the risk ratio, and the incidence odds ratio.
The rate ratio is the ratio of the incidence
rate in the exposed group (a/Y1) to that in
the nonexposed group (b/Y0). In the example
in Table 1, the incidence rates are 0.02 per
person-year in the exposed group and 0.01
per person-year in the nonexposed group, and
the rate ratio is therefore 2.00. A second
commonly used effect measure is the risk
ratio, which is the ratio of the incidence pro-
portion in the exposed group (a/N1) to that in
the nonexposed group (b/N0). In this example,
the risk ratio is 0.1813/0.0952 = 1.90. A third
possible effect measure is the incidence odds
ratio, which is the ratio of the incidence odds
in the exposed group (a/c) to that in the non-
exposed group (b/d). In this example, the odds
ratio is 0.2214/0.1052 = 2.11.
These three multiplicative effect measures
are sometimes referred to under the generic
term of relative risk. In this example, they all
show that the rate (or risk, or odds) of develop-
ing the disease under study is about twice as
high in the exposed group as in the nonexposed
group, but their precise estimates vary (2.00,
1.90, and 2.11, respectively). Thus, they are all
approximately equal when the disease is rare
during the follow-up period (e.g., an incidence
proportion < 10%). However, although the
rate ratio and (to a lesser extent) the risk ratio
are both commonly used for analyzing inci-
dence studies, the odds ratio has been severely
criticized as an effect measure (Greenland
1987; Miettinen and Cook 1981) and has lit-
tle intrinsic meaning in incidence studies.
Prevalence Studies
Incidence studies are the ideal method for
studying disease occurrence because they
involve collecting and analyzing all the rele-
vant information on the source population,
and we can get better information on when
exposure and disease occurred. However,
these types of studies involve lengthy periods
of follow-up and many resources in terms
of both time and funding, and it may be dif-
ficult to identify incident cases of nonfatal
chronic conditions such as diabetes or asthma.
Furthermore, in some instances we may be
more interested in factors that affect the cur-
rent burden of disease in the population.
Consequently, although incidence studies are
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There is still considerable confusion and debate about the appropriate methods for analyzing preva-
lence studies, and a number of recent papers have argued that prevalence ratios are the preferred
method and that prevalence odds ratios should not be used. These arguments assert that the preva-
lence ratio is obviously the better measure and the odds ratio is “unintelligible.” They have often
been accompanied by demonstrations that when a disease is common the prevalence ratio and the
prevalence odds ratio may differ substantially. However, this does not tell us which measure is the
more valid to use. In fact, the prevalence odds ratio a) estimates the incidence rate ratio with fewer
assumptions than are required for the prevalence ratio; b) can be estimated using the same methods
as for the odds ratio in case–control studies, namely, the Mantel–Haenszel method and logistic
regression; and c) provides practical, analytical, and theoretical consistency between analyses of a
prevalence study and prevalence case–control analyses based on the same study population. For
these reasons, the prevalence odds ratio will continue to be one of the standard methods for analyz-
ing prevalence studies and prevalence case–control studies. Key words: epidemiology, methods,
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Research Commentaryusually preferable, there is also an important
role for prevalence studies, for practical reasons
and because such studies enable the assessment
of the level of morbidity and the population
“disease burden” for a nonfatal condition
(Pearce 2003; Thompson et al. 1998).
Measures of effect in prevalence studies.
Figure 1 shows the relationship between inci-
dence and prevalence of disease in a “steady-
state” population. Suppose we denote the
prevalence of disease in the study population
by P, and we assume that the population is in
a steady state (stationary) over time (in that
the numbers within each subpopulation
deﬁned by exposure, disease, and covariates do
not change with time)—this usually requires
that incidence rates and exposure and disease
status are unrelated to the immigration and
emigration rates and population size, and that
average disease duration (D) does not change
over time. Then the prevalence odds is equal
to the incidence rate (I) times D (Alho 1992):
P— — — — — — — — — — — — — — — — — — — — — — — — — — — — —
(1 – P)
= ID. [1]
Now suppose that we compare two popu-
lations (indexed by 1 = exposed and 0 = non-
exposed) that both satisfy the above conditions.
Then, the prevalence odds is directly propor-
tional to the disease incidence, and the POR
satisﬁes the equation
POR = [P1/(1 – P1)]/[P0/(1 – P0)]
= I1D1/I0D0. [2]
An increased POR may thus reflect the
inﬂuence of factors that increase the duration
of disease as well as those that increase disease
incidence. A difference in prevalence between
two groups could depend entirely on differ-
ences in disease duration (e.g., because of
factors that prolong or exacerbate symptoms)
rather than differences in incidence. However,
in the special case where the average duration
of disease is the same in the exposed and non-
exposed groups (i.e., exposure has no effect on
duration), then the POR satisﬁes the equation
POR = [P1/(1 – P1)]/[P0/(1 – P0)] = I1/I0. [3]
That is, under the above assumptions, the
POR directly estimates the incidence rate ratio.
However, the prevalence ratio (P1/P0) only
approximately satisﬁes this equation provided
that the disease is rare and therefore (1 – P1)
and (1 – P0) are close to 1.0.
Of course, such a steady-state population
will rarely exist in practice, but it will be
approximated in situations where disease inci-
dence and the relevant exposures are not
changing markedly over time (provided the
other assumptions specified above are met).
This is also conditional on other risk factors
(e.g., age) because even when incidence is
independent of age, prevalence will often be
age dependent (Keiding 1991, 2000), and
these other risk factors therefore need to be
controlled for in the analysis.
Table 2 shows data from a prevalence
study of 20,000 people, with the data derived
from Table 1 using Equation 2 above. This is
based on the assumptions that, for both pop-
ulations, the incidence rate and population
size are constant over time, that the average
duration of disease is 5 years, and that there is
no migration of people with the disease into
or out of the population (such assumptions
may not be realistic but are made here for
purposes of illustration). In this situation, the
number of cases who “lose” the disease each
year is balanced by the number of new cases
generated from the source population. For
example, in the nonexposed group, there are
476 prevalent cases, and 95 (20%) of these
“lose” their disease each year; this is balanced
by the 95 people who develop the disease
each year (0.0100 of the susceptible popula-
tion of 9,524 people). One example of such a
condition would be childhood asthma, where
most children “lose” the condition after a few
years (5 years on average, in this hypothetical
example) whereas other children are acquiring
the condition for the first time; meanwhile,
the age-specific prevalence remains relatively
constant. With the additional assumption
that the average duration of disease is the
same in the exposed and nonexposed groups,
then the POR (2.00) validly estimates the
incidence rate ratio (Table 1).
Of course, when the above steady-state
assumptions are not met, which will frequently
be the case, then both the POR and the preva-
lence ratio will differ from the incidence rate
ratio (Thompson et al. 1998), and which
measure is more “valid” will be highly speciﬁc
to the population, exposure, and disease.
However, as the population pattern approaches
steady state, the POR increasingly estimates
the incidence rate ratio with greater validity
than does the prevalence ratio.
Prevalence case–control studies. Just as an
incidence case–control study can be used to
obtain the same findings as a full incidence
study, a prevalence case–control study can be
used to obtain the same findings as a full
prevalence study in a more efﬁcient manner.
In particular, if obtaining exposure informa-
tion is difficult or costly (e.g., if it involves
lengthy interviews, or serum samples), then it
may be more efﬁcient to conduct a prevalence
case–control study by obtaining exposure
information on all of the prevalent cases and a
sample of controls selected at random from
the noncases. For example, suppose a nested
case–control study is conducted in the study
population (Table 2), involving all of the
1,385 prevalent cases and a group of 1,385
controls selected from the noncases (Table 3).
The ratio of exposed to nonexposed controls
will estimate the exposure odds (b/d) of the
noncases, and the odds ratio obtained in the
prevalence case–control study will therefore
estimate the POR in the source population
(2.00), which in turn estimates the incidence
rate ratio, provided that the above assump-
tions are satisfied in the exposed and non-
exposed populations.
Which Effect Measure Should
We Use?
So which effect measure should we use to
analyze a prevalence study?
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Table 1. Findings from a hypothetical cohort study of 20,000 persons followed for 10 years.
Exposed Nonexposed Ratio
Cases 1,813 (a) 952 (b)
Noncases 8,187 (c) 9,048 (d)
Total population 10,000 (N1) 10,000 (N0)
Person-years 90,635 (Y1) 95,163 (Y0)
Incidence rate 0.0200 (I1) 0.0100 (I0) 2.00
Incidence proportion (average risk) 0.1813 (R1) 0.0952 (R0) 1.90
Incidence odds 0.2214 (O1) 0.1052 (O0) 2.11
Figure 1. Relationship between prevalence and inci-
dence in a steady-state population. Abbreviations: D,
duration; I, incidence; N, population; P, prevalence.
N(1 – P) × I
NP/D
Cases
[NP] Noncases
[N(1 – P)]
Table 2. Findings from a hypothetical prevalence
study of 20,000 persons.
Exposed Nonexposed Ratio
Cases 909 (a) 476 (b)
Noncases 9,091 (c) 9,524 (d)
Total population 10,000 (N1) 10,000 (N0)
Prevalence 0.0909 (P1) 0.0476 (P0) 1.91
Prevalence odds 0.1000 (O1) 0.0500 (O0) 2.00
Data are derived from Table 1 using Equation 2 based on the
assumptions that, for both populations, the incidence rate
and population size are constant over time, that the average
duration of disease is 5 years, and that there is no migration
of people with the disease into or out of the population.Reasons for using the POR. There are a
number of reasons why the use of the POR is
attractive. First, although this is not always
the case, prevalence studies are frequently
conducted to learn more about the risk fac-
tors for a disease; that is, they are conducted
to find out how to prevent the incidence of
the disease. In this situation, incidence is the
effect measure of interest. As shown above,
provided that certain (admittedly restrictive)
assumptions are met, the POR provides an
unbiased estimate of the incidence rate ratio.
On the other hand, for the prevalence ratio to
provide such an unbiased estimate requires
that all of the same assumptions are met, plus
the additional assumption that the disease is
rare. Thus, when the incidence rate ratio is
the real effect measure of interest, the POR
will estimate this with fewer assumptions than
are required for the prevalence ratio.
A second reason often given for using
the POR is ease of computation, because
the POR can be calculated using standard
methods for case–control studies such as the
Mantel–Haenszel (1959) method or logistic
regression (Rothman and Greenland 1998).
This has obvious practical advantages because
of the widespread availability and use of
appropriate computer packages. Logistic
regression or the proportional hazards model
can also be used to estimate the prevalence
ratio, but this is not straightforward and esti-
mation may be intractable in the presence of
many covariates (Thompson et al. 1998).
However, this “problem” with using the preva-
lence ratio is more imaginary than real because
standard methods can be used to model preva-
lences, just as they can be used to model risks
(both prevalence and risk are expressed as a
proportion; Tables 1 and 2). These include the
Mantel–Haenszel method for risk/prevalence
(pure count data; Rothman and Greenland
1998), and (exponential) risk regression
(Zocchetti et al. 1995). It is sometimes argued
that (exponential) risk regression is inappropri-
ate because it may yield predicted values of the
prevalence that are < 0 or > 1 (Lee 1995), but
this is rarely a problem in practice (Rothman
and Greenland 1998). It is also argued that
only a few explanatory variables can be accom-
modated because cross-classiﬁcation will yield
many cells without at least one prevalence case
(Lee 1995). However, the Mantel–Haenszel
method for risk:prevalence ratios is relatively
robust, just as the Mantel–Haenszel method
for odds ratios is (Rothman and Greenland
1998). Similarly, (exponential) risk regression
using maximum likelihood methods performs
just as well as logistic regression does for
estimating odds ratios. Thus, this “computa-
tional” argument for using PORs rather than
prevalence ratios is invalid.
However, there is a third reason for using
PORs that is rarely mentioned: that it pro-
vides consistency between prevalence studies
and prevalence case–control studies based on
the same population. It is frequently the case
that a prevalence study is conducted first to
identify cases and noncases for a chronic con-
dition such as asthma or diabetes, and that all
of the identified cases and a control sample
(chosen from the noncases) are then selected
for further investigation. For example, phase I
of the International Study of Asthma and
Allergies in Childhood (Asher et al. 1995;
Pearce et al. 1993) involved asthma preva-
lence studies in children in 155 centers in
56 countries (Beasley et al. 1998), and the
initial prevalence studies were in many
instances used as basis for more detailed
prevalence case–control studies (e.g., Wickens
et al. 1999). Such an approach is practical and
logical because it is not necessary to obtain
detailed information (e.g., more detailed
questionnaires, skin prick testing, blood tests)
for the entire study population; rather, it is
more efﬁcient to obtain it for all of the cases
and a sample of the noncases. In prevalence
case–control studies the prevalence odds ratio
is the standard effect measure, just as in an
incidence case–control study the (incidence)
odds ratio is the standard effect measure
(Morgenstern and Thomas 1993; Pearce
1998). Furthermore, provided that controls
are sampled without bias, the POR in a
prevalence case–control study will provide an
unbiased estimate of the POR that would
have been obtained in a full prevalence study
based on the same source population. There
are therefore obvious beneﬁts, both practically
and conceptually, with using the POR in a
full prevalence study to provide theoretic and
analytic consistency between the analysis of
the full prevalence study and any prevalence
case–control analyses that may be conducted
in the same population.
Reasons for using the prevalence ratio. So
why doesn’t everyone use the POR? One argu-
ment is that when a disease is common, then
the POR and the prevalence ratio may differ
greatly, and there may also be differences in
the nature and extent of confounding and
effect modification (Thompson et al. 1998).
However, the fact that the two methods give
different results when the disease is common
(they give very similar results when the disease
is rare) does not tell us which measure is more
appropriate to use. Rather, it emphasizes the
importance of using the measure that is most
appropriate for the task.
A second argument is that “the odds ratio is
incomprehensible” (Lee 1994). However, this
assertion is based on a misquoting of the litera-
ture (e.g., Greenland 1987), which shows that
the odds ratio is not a meaningful effect meas-
ure in a cohort study. This tells us nothing
about the use of the odds ratio in other con-
texts. In particular, the odds ratio is the stan-
dard effect measure in an (incidence) case–
control study and, provided that the controls
have been selected appropriately, will estimate
the incidence rate ratio without the need for
any rare disease assumption (Pearce 1993).
Similarly, as shown above, provided a number
of more restrictive assumptions are made, the
POR is not only a meaningful effect measure
in a prevalence study, but will also estimate the
incidence rate ratio with fewer assumptions
than are required for the prevalence ratio.
What is incomprehensible and inappropriate
for use in a cohort study may be quite compre-
hensible and appropriate for use in a incidence
case–control study or a prevalence study.
A third and related argument is that the
prevalence ratio has greater “natural intelligibil-
ity” (Axelson et al. 1994; Lee and Chia 1993;
Thompson et al. 1998). For example, Lee and
Chia (1993) argue that “whereas PR [preva-
lence ratio] is easy to interpret and to commu-
nicate, POR lacks intelligibility.” However,
what is most intelligible and interpretable
to one person may not be so to another.
Moreover, the most intelligible measures may
not be the most valid. For example, using the
same logic, one might argue that the ratio of
the percentage of cases exposed to the percent-
age of controls exposed in an (incidence)
case–control study (the exposure ratio) is more
intelligible and easier to communicate than is
the (exposure) odds ratio. Moreover, it could
be argued that there is good evidence for this
given the confusion about the odds ratio, and
what it is estimating in an (incidence) case–
control study, that stretches back for nearly
50 years (Pearce 1993). Nevertheless, the odds
ratio is the standard effect measure to use in
an (incidence) case–control study despite its
lack of “natural intelligibility.”
A ﬁnal argument for using the prevalence
ratio is that sometimes we are interested in
prevalence itself, rather than incidence, and
that in this situation the prevalence ratio is
clearly the effect measure of interest—for
example, when we are concerned about the
public health burden of disease. This argu-
ment clearly has merit, albeit with the qualiﬁ-
cation that in this situation it is often the
absolute value of prevalence and the preva-
lence difference that are of greatest interest,
rather than the prevalence ratio.
Conclusion
A number of authors have argued that the
prevalence ratio is the preferable effect measure
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Table 3. Findings from a hypothetical prevalence
case–control study based on the population repre-
sented in Table 1.
Exposed Nonexposed Ratio
Cases 909 (a) 476 (b)
Controls 676 (c) 709 (d)
Prevalence odds 1.34 (O1) 0.67 (O0) 2.00to use in prevalence studies. The case for using
the prevalence ratio essentially reduces to the
assertion that it is obviously the better measure
whereas the odds ratio is “unintelligible,” and
that when a disease is common the prevalence
ratio and the POR may differ substantially.
However, although such analyses are valuable
in indicating how much the two measures may
diverge, and under what circumstances, they
do not solve the problem as to which measure
is the most appropriate to use. A more valid
argument is that the prevalence ratio is the
effect measure of interest when we are inter-
ested in the public health burden of disease,
although in this situation the absolute preva-
lence and the prevalence difference are usually
of more interest. However, when we are inter-
ested in disease etiology, the POR a) estimates
the incidence rate ratio with fewer assumptions
than are required for the prevalence ratio;
b) can be estimated using the same methods
as for the odds ratio in case–control studies,
namely, the Mantel–Haenszel method and
logistic regression; and c) provides practical,
analytical, and theoretical consistency between
analyses of a prevalence study and those of a
prevalence case–control study based on the
same study population. For these reasons, the
POR will continue to be one of the standard
methods for analyzing prevalence studies and
prevalence case–control studies.
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